Nanoviricides Inc (NNVC)
2.40
-0.03
(-1.23%)
USD |
NYAM |
May 31, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Nanoviricides Shareholders Equity (Quarterly): 10.65M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.65M |
December 31, 2023 | 12.45M |
September 30, 2023 | 12.97M |
June 30, 2023 | 14.87M |
March 31, 2023 | 18.23M |
December 31, 2022 | 19.87M |
September 30, 2022 | 21.56M |
June 30, 2022 | 23.08M |
March 31, 2022 | 24.76M |
December 31, 2021 | 26.47M |
September 30, 2021 | 28.31M |
June 30, 2021 | 29.91M |
March 31, 2021 | 31.89M |
December 31, 2020 | 27.75M |
September 30, 2020 | 29.98M |
June 30, 2020 | 21.76M |
March 31, 2020 | 14.31M |
December 31, 2019 | 7.722M |
September 30, 2019 | 9.130M |
June 30, 2019 | 10.60M |
March 31, 2019 | 12.72M |
December 31, 2018 | 13.84M |
September 30, 2018 | 15.98M |
June 30, 2018 | 17.66M |
March 31, 2018 | 19.15M |
Date | Value |
---|---|
December 31, 2017 | 15.92M |
September 30, 2017 | 18.52M |
June 30, 2017 | 20.32M |
March 31, 2017 | 22.41M |
December 31, 2016 | 19.15M |
September 30, 2016 | 20.23M |
June 30, 2016 | 23.05M |
March 31, 2016 | 23.98M |
December 31, 2015 | 28.38M |
September 30, 2015 | 30.71M |
June 30, 2015 | 31.79M |
March 31, 2015 | 31.86M |
December 31, 2014 | 30.51M |
September 30, 2014 | 36.83M |
June 30, 2014 | 23.37M |
March 31, 2014 | 32.03M |
December 31, 2013 | 10.21M |
September 30, 2013 | 11.75M |
June 30, 2013 | 8.010M |
March 31, 2013 | 10.12M |
December 31, 2012 | 14.21M |
September 30, 2012 | 12.80M |
June 30, 2012 | 13.85M |
March 31, 2012 | 13.57M |
December 31, 2011 | 12.39M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.722M
Minimum
Dec 2019
31.89M
Maximum
Mar 2021
19.81M
Average
20.72M
Median
Shareholders Equity (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | 249.93M |
Enanta Pharmaceuticals Inc | 166.11M |
GlycoMimetics Inc | 28.91M |
FibroGen Inc | -228.12M |
Corvus Pharmaceuticals Inc | 33.36M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 11.46M |
Total Liabilities (Quarterly) | 0.8133M |